| Literature DB >> 32847818 |
Catherine E Hassett1, Aron Gedansky1, Ibrahim Migdady2, Adarsh Bhimraj3, Ken Uchino4, Sung-Min Cho5.
Abstract
Patients with COVID-19 have a fairly high risk of neurologic complications, including encephalopathy, stroke, central nervous system infection, seizures, and neuromuscular diseases. Many report losing their senses of smell and taste, and many survivors report lingering neurocognitive impairment. The diagnosis and treatment of these complications does not differ from that in other patients, although sophisticated testing may not be readily available for a patient in intensive care and respiratory isolation. Clinicians should therefore be alert to these complications.Entities:
Mesh:
Year: 2020 PMID: 32847818 DOI: 10.3949/ccjm.87a.ccc058
Source DB: PubMed Journal: Cleve Clin J Med ISSN: 0891-1150 Impact factor: 2.321